Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AtrimusRX AB
AB
Active
Org 5590660725
Hammarbacken 6 A, 191 49
Sollentuna
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2016
11 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
AtrimusRX AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
85M
171M
256M
342M
139M
2020
157M
2021
190M
2022
297M
2023
154M
2024
EBITDA
SEK millions
0M
18M
36M
53M
71M
62M
2020
27M
2021
41M
2022
54M
2023
24M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
139 262
157 137
189 762
297 454
154 444
Staff expenses
—
—
—
−6 999
−8 648
EBITDA
62 433
27 177
40 512
54 406
23 775
Depreciation & amort.
−303
−548
−587
−502
−585
EBIT
62 130
26 629
39 925
53 904
23 190
Net financials
−46
59
−37
−2 380
3 323
Profit before tax
62 084
26 688
39 887
51 524
19 714
Tax
−13 299
−5 511
−8 228
−10 631
−4 202
Net profit
48 785
21 177
31 659
40 893
15 512
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
65 555
64 986
59 019
105 587
65 522
Equity
49 947
24 724
36 384
47 277
42 789
Long-term debt
0
0
0
—
—
Short-term debt
15 608
40 262
22 636
58 311
15 934
Total debt
15 608
40 262
22 636
58 311
15 934
Financial ratios
5-year trend
EBITDA margin
15.4%
This company
15.8%
Market median
+3% vs market
2020
2024
Equity ratio
65.3%
This company
38.2%
Market median
+71% vs market
2020
2024
Return on equity
36.3%
This company
18.4%
Market median
+97% vs market
2020
2024
Net profit margin
10.0%
This company
8.1%
Market median
+23% vs market
2020
2024
Asset turnover
2.36×
This company
1.12×
Market median
+111% vs market
2020
2024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on AtrimusRX AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
